In 1998 was created Nesta Ventures, which is appeared as VC. The venture was found in Europe in United Kingdom. Nesta Ventures appeared to be a CVC structure as part of the corporation. The leading representative office of defined VC is situated in the London.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Nesta Ventures, startups are often financed by Oxford Capital Partners, Seraphim Capital, Providence Investment Company Limited. The meaningful sponsors for the fund in investment in the same round are Imperial Innovations, YFM Equity Partners, Oxford Capital Partners. In the next rounds fund is usually obtained by YFM Equity Partners, Oxford Capital Partners, Morningside Venture Partners.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular fund investment industries, there are Manufacturing, Hardware. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Featurespace, Light Blue Optics, Veryan Medical.
The top activity for fund was in 2017. Opposing the other organizations, this Nesta Ventures works on 19 percentage points less the average amount of lead investments. The average startup value when the investment from Nesta Ventures is 1-5 millions dollars. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 5 - 10 millions dollars. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2018.
Besides them, we counted 3 critical employees of this fund in our database.
Funds with similar focus
Fund Name | Location |
4.0 Partners | California, San Francisco, United States |
Alterfin | Belgium, Brussels Hoofdstedelijk Gewest, Brussels-Capital |
Altpoint Capital Partners | New York, New York, United States |
Bonsai Partners | Community of Madrid, Madrid, Spain |
Cafe Company | Chiyoda, Japan |
ChetritGroup | New York, New York, United States |
Commonwealth Corporation | - |
CVC Credit Partners | England, London, United Kingdom |
Energy Ventures | Canada, Ontario, Ottawa |
ENERN Investments | Czechia, Prague, Prague |
First Ascent Associates | California, San Francisco, United States |
First Beverage Group | California, Los Angeles, United States |
Management Angels | Germany, Hamburg |
Marker Hill Capital | Colorado, Denver, United States |
MILFAM | - |
New Hill Management | England, London, United Kingdom |
Proeza Ventures | Mexico, Nuevo León, Nuevo Leon |
Rocky Mountain Institute (RMI) | Colorado, Snowmass, United States |
Tohoku University Venture Partners | Japan, Miyagi Prefecture, Sendai |
Vitality Capital | Canada, Ontario, Toronto |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Citymart | 19 Mar 2018 | New York, United States | |||
$2M | 02 Jun 2017 | East Cambridgeshire, England, United Kingdom | |||
Cytox | $3M | 01 Jun 2017 | United Kingdom, England | ||
Skimlinks | 11 Nov 2011 | London, England, United Kingdom | |||
Haemostatix | 01 Aug 2011 | Nottingham, England, United Kingdom | |||
CellNovo | $41M | 04 Feb 2011 | Allerdale, England, United Kingdom | ||
Kaptivo | $13M | 11 Oct 2010 | California, United States | ||
BaseKit | $2M | 15 Jun 2010 | England | ||
Veryan Medical | $5M | 05 Apr 2010 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Citymart | 19 Mar 2018 | New York, United States | |||
$2M | 02 Jun 2017 | East Cambridgeshire, England, United Kingdom | |||
Cytox | $3M | 01 Jun 2017 | United Kingdom, England | ||
Skimlinks | 11 Nov 2011 | London, England, United Kingdom | |||
Haemostatix | 01 Aug 2011 | Nottingham, England, United Kingdom | |||
CellNovo | $41M | 04 Feb 2011 | Allerdale, England, United Kingdom | ||
Kaptivo | $13M | 11 Oct 2010 | California, United States | ||
BaseKit | $2M | 15 Jun 2010 | England | ||
Veryan Medical | $5M | 05 Apr 2010 | England |